Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1313 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Emergent begins Phase Ib/II TRU-016 study

The company expects to recruit around 114 bendamustine-naive patients with a confirmed diagnosis of relapsed CLL and who have failed up to three previous treatments. In the Phase

Mannatech starts business operations in Mexico

The company’s Mexico operations include offices and storefronts in both Guadalajara and Mexico City, and a distribution centre located in Monterrey. Mannatech president Randy Bancino said Mexico is

USPTO issues new patent to Progen Pharma

The patent entitiled ‘Sulfated Oligosaccharide Derivatives’ protects Progen’s PG500 series of small molecule compounds and their use in a variety of therapeutic areas predominantly related to oncology. Progen

Amgen sets to take over BioVex

BioVex is a biotechnology company that develops OncoVEX (GM-CSF), a novel oncolytic vaccine in Phase 3 clinical development, intended as a treatment for melanoma and head and neck